PHYTONADIONE, (E)-(±)-
Tuberous Sclerosis Complex (TSC)
GRIN Therapeutics, Inc.Small moleculePhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
12 Active assets in the Tuberous Sclerosis Complex (TSC) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carbamazepine GRIN Therapeutics, Inc. | Phase 3 | BB |
Ycj-01 Full Spectrum Cannbis Extract Oils4Cure | Phase 3 | B |
Radiprodil GRIN Therapeutics, Inc. | Phase 1/2 | CCC |
svg103 Sovargen | Phase 1/2 | CC |
DYNAMOS GRIN Therapeutics, Inc. | Phase 1 | CC |
View all 12 →
Same molecule, other indications
PHYTONADIONE, (E)-(±)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →